Occudo Quantitative Strategies’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-532
Closed -$48K 1454
2022
Q2
$48K Buy
+532
New +$48K ﹤0.01% 1073